Journal issues > Issue 5, September 2019 > Highlights in multiple myeloma

Highlights in multiple myeloma

SUMMARY

Over the last few years, the treatment landscape for patients with multiple myeloma (MM) changed dramatically. Also the 2019 annual meeting of the European Hematology Association featured several interesting MM abstracts. In this article we will discuss 6 highlights from the meeting. For a more complete overview of MM news at EHA 2019 we would like to refer to the congress website (https://ehaweb.org/congress/previous-congresses/eha24/abstracts-online-2/).

(BELG J HEMATOL 2019;10(5):203–7)

To read the full artice you have the following options:

* (only possible for healthcare professionals with RIZIV/INAMI/MATRICULE working in the field of Hematology in Belgium and Luxembourg with prescription authorisation)

Purchase this article for €2.42

** (for healthcare professionals with prescribing authorisation working outside the field of Hematology in Belgium and Luxembourg as well as those without prescribing authorisation working as healthcare professional in Hematology in Belgium and Luxembourg, plus persons without prescription authorisation working outside Belgium and Luxembourg, plus healthcare professionals with prescribing authorisation outside Belgium and Luxembourg plus non-healthcare professionals from outside or inside Belgium or Luxembourg)

Top